Xarelto lawsuits allege bloodthinning drug poses risk of serious injury, death from excess bleeding

Posted
by Michael Heygood

Some of the people pursuing Xarelto bleeding lawsuits have requested that all Xaretlo cases pending in federal courts around the country be brought together in a single U.S. district court for pre-trial proceedings. The request, filed with the United States Judicial Panel of Multidistrict Litigation (JPML), proposes a multidistrict proceeding to oversee all federal Xarelto cases before United States District Judge David R. Herndon in the Southern District of Illinois.

Blood-thinners can be prescribed for patients with atrial fibrillation to lower their risk of heart attack and stroke. Xarelto has been marketed as an effective and convenient alternative to the blood-thinner warfarin. Warfarin thins the blood by blocking vitamin K, and requires regular monitoring and special dietary restrictions. Xarelto does not require such monitoring or a special diet.

However, there is another very important difference between Xarelto and warfarin, and patients allege that they were not told about this other difference. Patients that bleed while taking warfarin can take vitamin K to reverse the effects of the drug and stop the bleeding. There is no similar antidote for Xarelto. In other words, if a patient suffers an uncontrollable bleeding event, there is nothing similar to vitamin K for warfarin that can be given to the patient to reverse the effects of Xarelto.

Lawsuits have been filed alleging that such bleeding events have led to serious injury and even death among patients taking Xarelto. The lawsuits allege that the manufacturer of the drug failed to warn critical care medical professionals that there is no effective agent to reverse the effects of Xarelto, and failed to warn patients that if serious bleeding occurs, there is a chance the effects would be irreversible and life-threatening.

There are more than twenty Xarelto lawsuits already pending in federal courts across the country, according to the request to create a multidistrict litigation, or MDL. The JPML creates an MDL proceeding when numerous lawsuits involve common questions of fact and law and coordination will not only promote the convenience of the parties but ensure “just and efficient” proceedings.

The plaintiffs seeking coordination argue that the multiple lawsuits rise common questions such whether Xarelto was properly marketed and labeled, whether Xarelto was adequately tested, and whether the defendants provided adequate warnings about the risks of Xarelto. The JPML is likely to consider whether to coordinate Xarelto bleeding lawsuits in federal courts in December or January.

Heygood, Orr & Pearson fighting for safer drugs

At Heygood, Orr & Pearson, we believe that when drugmakers fail to properly warn patients about risk of complications from prescription drugs and other pharmaceutical products, they should be held responsible for their negligent actions in a court of law. Our attorneys have fought for years to ensure that drug and medical device companies who engage in reckless conduct are held responsible for their actions.

Over the last few years, we have collected more than $200 million for our clients in lawsuits relating to defective pharmaceutical products. From pharmaceutical liability cases involving the fentanyl pain patch or defective drugs such as Yaz and Yasmin, Actos, Avandia, and Pradaxa to lawsuits filed against the makers of defective hip and knee replacements and other medical devices, our law firm has made it a career priority to ensure that the makers of these dangerous products are held responsible

To successfully bring a claim against big and well-funded drug companies, clients need an experienced, educated attorney on their side. They also need an attorney with the financial resources to take the case to trial. At Heygood, Orr & Pearson, we have tried hundreds of cases to verdict and have settled hundreds more.

Heygood, Orr & Pearson are very comfortable and experienced with the complex and challenging world of “multidistrict litigation.” As one example, Michael Heygood and other lawyers at Heygood, Orr & Pearson were designated “Lead Plaintiffs’ Counsel” last year by the federal court that presided over numerous wrongful death lawsuits regarding the Watson fentanyl patch that were consolidated for pretrial purposes in MDL No. 2372 — In re: Watson Fentanyl Patch Products Liability Litigation, before the United States District Court for the Northern District of Illinois.

If you have been injured or have lost a loved one because of Xarelto or because of defective or dangerous prescription drugs or medical devices, you deserve proper compensation. To receive a free consultation about your case and learn more about your legal rights, contact the lawyers at Heygood, Orr & Pearson by calling toll-free at 1-877-446-9001, or by filling out our free case evaluation form located on this website.